The history of neurosurgery at Temple University.

TEMPLE UNIVERSITY'S NEUROSURGERY program has had a colorful and distinguished history since its creation in 1929. It has always functioned under challenging circumstances with limited resources but with a strong sense of mission. It was one of the 20 neurosurgical training programs in existence when the American Board of Neurosurgery was founded in 1940. Over the past 64 years, the program has trained approximately the same number of neurosurgeons, many of whom have contributed significantly to our specialty. Some of the advances pioneered in part at Temple include clinical hypothermia (Fay), the biplanar stereoscopic angiographic unit (Chamberlain), human stereotactic surgery (Spiegel and Wycis), lumboperitoneal shunts (Scott), posterior lumbar interbody fusion (Lin), microsurgery for acoustic tumors (Buchheit), and new pharmacological approaches to neuroprotectors (Strauss and Narayan). The Temple neurosurgery program has survived many challenges in the past and will no doubt weather the current financial and medicolegal challenges that confront the neurosurgical community in Philadelphia. It remains a strong clinical program that serves an otherwise underserved community and attracts patients beyond its geographic area because of its strong clinical reputation and the excellence of its clinical faculty and residents.

Current results of the surgical management of acoustic neuroma.

A retrospective analysis of 162 consecutive cases in 160 patients who underwent microsurgical resection of vestibular schwannomas between October 1995 and June 2001 was undertaken to compare the results with those of other treatment modalities. Patient hospital records, operative video pictures, neuroimaging studies, audiograms, and follow-up data were reviewed. The mean follow-up period was 24 months.There were 34 small (<1.5 cm), 92 medium (1.5-3 cm), and 36 (>3 cm) large tumors. Six were recurrent tumors. Gross total resection was accomplished in all 34 small tumors and 92 medium tumors but only in 50% of the large tumors. Among the 126 small and medium tumors, the facial nerve was saved anatomically in 124 patients. On long-term follow up, facial function was preserved in 94.4% of all patients. Anatomically, the cochlear nerve was preserved in 55.9% of the small and 20.7% of the medium tumors. Function was preserved (Gardner-Robertson class 1 and 2) in 25% of the small and in 19.4% of the medium tumors. Cerebrospinal leakage was present in 10.5%, meningitis in 9.9%, wound infection in 3.7%, and hematoma or contusion in 2.5%. Only one patient died (mortality rate 0.6%). Our data reflect that surgical removal should be the standard management for acoustic tumors, particularly for large and medium tumors, and can be accomplished with acceptable complication rates.